DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC Holdings

DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC is an investment fund managing more than 275.83M US dollars. The largest holdings include Alpine Immune Sciences, Zentalis Pharmaceuticals and Cue Health. In Q3 2022 the fund bought assets of total value of 12.99M US dollars and sold assets of total value of 4.09M US dollars.

$275.82M

portfolio value

-4.79%

quarter

DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q3 2022	12988000	4094000

DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Alpine Immune Sciences, Inc. Portfolio share: 17.51% Portfolio value: 48.3M Avg. open price: $8.51 Current price: $6.5 P/L: -23.62% Bought +42.48% shares Q3 2022	share	17.51%	48.3M	$8.51	$6.5	-23.62%	Bought +42.48% shares Q3 2022
Biotechnology Zentalis Pharmaceuticals, Inc. Portfolio share: 14.33% Portfolio value: 39.52M Avg. open price: N/A Current price: $21.89 P/L: N/A N/A Q2 2022	share	14.33%	39.52M	N/A	$21.89	N/A	N/A Q2 2022
Health Information Services Cue Health Inc. Portfolio share: 9.80% Portfolio value: 27.03M Avg. open price: N/A Current price: $3.05 P/L: N/A N/A Q1 2022	share	9.80%	27.03M	N/A	$3.05	N/A	N/A Q1 2022
Diagnostics & Research Illumina, Inc. Portfolio share: 9.00% Portfolio value: 24.82M Avg. open price: N/A Current price: $218.76 P/L: N/A Sold -15.63% shares Q3 2022	share	9.00%	24.82M	N/A	$218.76	N/A	Sold -15.63% shares Q3 2022
Biotechnology Arcus Biosciences, Inc. Portfolio share: 8.25% Portfolio value: 22.75M Avg. open price: N/A Current price: $35.71 P/L: N/A N/A Q1 2022	share	8.25%	22.75M	N/A	$35.71	N/A	N/A Q1 2022
Biotechnology Prometheus Biosciences, Inc. Portfolio share: 5.35% Portfolio value: 14.75M Avg. open price: N/A Current price: $40 P/L: N/A N/A Q1 2022	share	5.35%	14.75M	N/A	$40	N/A	N/A Q1 2022
Biotechnology Albireo Pharma, Inc. Portfolio share: 4.38% Portfolio value: 12.06M Avg. open price: $19.86 Current price: $23.78 P/L: +19.74% Bought +20.26% shares Q3 2022	share	4.38%	12.06M	$19.86	$23.78	+19.74%	Bought +20.26% shares Q3 2022
Health Information Services 10x Genomics, Inc. Portfolio share: 3.71% Portfolio value: 10.24M Avg. open price: $45.25 Current price: $38.97 P/L: -13.88% Bought +18.28% shares Q3 2022	share	3.71%	10.24M	$45.25	$38.97	-13.88%	Bought +18.28% shares Q3 2022
Biotechnology Equillium, Inc. Portfolio share: 3.58% Portfolio value: 9.87M Avg. open price: N/A Current price: $1.66 P/L: N/A N/A Q1 2022	share	3.58%	9.87M	N/A	$1.66	N/A	N/A Q1 2022
Medical Devices Pacific Biosciences of California, Inc. Portfolio share: 3.08% Portfolio value: 8.50M Avg. open price: N/A Current price: $10.66 P/L: N/A N/A Q1 2022	share	3.08%	8.50M	N/A	$10.66	N/A	N/A Q1 2022
Biotechnology Adicet Bio, Inc. Portfolio share: 2.99% Portfolio value: 8.24M Avg. open price: N/A Current price: $19.26 P/L: N/A N/A Q1 2022	share	2.99%	8.24M	N/A	$19.26	N/A	N/A Q1 2022
Biotechnology Aadi Bioscience, Inc. Portfolio share: 2.70% Portfolio value: 7.43M Avg. open price: N/A Current price: $13.4 P/L: N/A N/A Q1 2022	share	2.70%	7.43M	N/A	$13.4	N/A	N/A Q1 2022
Biotechnology Mersana Therapeutics, Inc. Portfolio share: 2.22% Portfolio value: 6.11M Avg. open price: N/A Current price: $7.25 P/L: N/A N/A Q1 2022	share	2.22%	6.11M	N/A	$7.25	N/A	N/A Q1 2022
Apexigen, Inc. Portfolio share: 1.85% Portfolio value: 5.11M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2022	share	1.85%	5.11M	N/A	N/A	N/A	N/A Q3 2022
Biotechnology BeyondSpring Inc. Portfolio share: 1.78% Portfolio value: 4.90M Avg. open price: $1.44 Current price: $0.57 P/L: -60.26% Bought 0.00% shares Q3 2022	share	1.78%	4.90M	$1.44	$0.57	-60.26%	Bought 0.00% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 1.77% Portfolio value: 4.88M Avg. open price: $79.76 Current price: $104.85 P/L: +31.46% Bought +42.42% shares Q3 2022	share	1.77%	4.88M	$79.76	$104.85	+31.46%	Bought +42.42% shares Q3 2022
Biotechnology Terns Pharmaceuticals, Inc. Portfolio share: 1.53% Portfolio value: 4.20M Avg. open price: N/A Current price: $6.41 P/L: N/A N/A Q1 2022	share	1.53%	4.20M	N/A	$6.41	N/A	N/A Q1 2022
Biotechnology Aura Biosciences, Inc. Portfolio share: 1.38% Portfolio value: 3.80M Avg. open price: N/A Current price: $13.12 P/L: N/A N/A Q1 2022	share	1.38%	3.80M	N/A	$13.12	N/A	N/A Q1 2022
Biotechnology Seagen Inc. Portfolio share: 1.14% Portfolio value: 3.14M Avg. open price: N/A Current price: $122.41 P/L: N/A N/A Q3 2022	share	1.14%	3.14M	N/A	$122.41	N/A	N/A Q3 2022
Health Information Services Sema4 Holdings Corp. Portfolio share: 1.09% Portfolio value: 3.00M Avg. open price: N/A Current price: $0.42 P/L: N/A N/A Q1 2022	share	1.09%	3.00M	N/A	$0.42	N/A	N/A Q1 2022
Argenx SE Portfolio share: 0.71% Portfolio value: 1.95M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2022	share	0.71%	1.95M	N/A	N/A	N/A	N/A Q3 2022
Medical Instruments & Supplies AtriCure, Inc. Portfolio share: 0.66% Portfolio value: 1.80M Avg. open price: N/A Current price: $45.56 P/L: N/A N/A Q1 2022	share	0.66%	1.80M	N/A	$45.56	N/A	N/A Q1 2022
Drug Manufacturers—Specialty & Generic SCYNEXIS, Inc. Portfolio share: 0.48% Portfolio value: 1.33M Avg. open price: N/A Current price: $2.3 P/L: N/A N/A Q1 2022	share	0.48%	1.33M	N/A	$2.3	N/A	N/A Q1 2022
Medical Devices Owlet, Inc. Portfolio share: 0.35% Portfolio value: 961K Avg. open price: N/A Current price: $0.77 P/L: N/A N/A Q1 2022	share	0.35%	961K	N/A	$0.77	N/A	N/A Q1 2022
Biotechnology Nautilus Biotechnology, Inc. Portfolio share: 0.23% Portfolio value: 636K Avg. open price: N/A Current price: $1.78 P/L: N/A N/A Q1 2022	share	0.23%	636K	N/A	$1.78	N/A	N/A Q1 2022
Biotechnology NeuBase Therapeutics, Inc. Portfolio share: 0.14% Portfolio value: 395K Avg. open price: N/A Current price: $0.24 P/L: N/A N/A Q1 2022	share	0.14%	395K	N/A	$0.24	N/A	N/A Q1 2022
Medical Instruments & Supplies Singular Genomics Systems, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.04 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.04	N/A	Sold -100.00% shares Q3 2022
Medical Devices 908 Devices Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $10.37 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$10.37	N/A	Sold -100.00% shares Q3 2022

Showing TOP 28 DECHENG CAPITAL MANAGEMENT III (CAYMAN)'s 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC?

The biggest position of the DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC is Alpine Immune Sciences, Inc. (ALPN) with 17.51% portfolio share worth of 48.3M US dollars.

Top 5 DECHENG CAPITAL MANAGEMENT III (CAYMAN)'s holdings represent 58.89% of the portfolio:

Alpine Immune Sciences, Inc. (ALPN) – 17.51%
Zentalis Pharmaceuticals, Inc. (ZNTL) – 14.33%
Cue Health Inc. (HLTH) – 9.8%
Illumina, Inc. (ILMN) – 9%
Arcus Biosciences, Inc. (RCUS) – 8.25%

Who is the portfolio manager of DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC?

The portfolio manager of the DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC is .

What is the total asset value of the DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC portfolio?

DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC total asset value (portfolio value) is 275.83M US dollars.

Who is ?

is the portfolio manager of the DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC.

What is (DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC) fund performance?

DECHENG CAPITAL MANAGEMENT III (CAYMAN)'s quarterly performance is -4.79%, annualy 0.00%.

What is the DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC CIK?

DECHENG CAPITAL MANAGEMENT III (CAYMAN)'s Central Index Key is 0001747821 .